Tag | Content |
---|
EnhancerAtlas ID | HS051-14121 |
Organism | Homo sapiens |
Tissue/cell | Fetal_thymus |
Coordinate | chr19:30161390-30164730 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
MEF2A | MA0052.3 | chr19:30162545-30162557 | GCTAAAAATAGC | + | 6.44 | MEF2B | MA0660.1 | chr19:30162545-30162557 | GCTAAAAATAGC | + | 6.92 | MEF2C | MA0497.1 | chr19:30162543-30162558 | AAGCTAAAAATAGCA | + | 8.03 | NFE2L1 | MA0089.2 | chr19:30162847-30162862 | AGAGCTGAGTCATGC | - | 6.23 | REL | MA0101.1 | chr19:30164516-30164526 | GGAAATCCCC | - | 6.02 |
|
| Number of super-enhancer constituents: 23 | ID | Coordinate | Tissue/cell |
SE_01995 | chr19:30162190-30164011 | Aorta | SE_03500 | chr19:30162856-30163592 | Brain_Angular_Gyrus | SE_04418 | chr19:30161971-30164004 | Brain_Anterior_Caudate | SE_05104 | chr19:30161943-30175216 | Brain_Cingulate_Gyrus | SE_05992 | chr19:30161895-30175512 | Brain_Hippocampus_Middle | SE_07189 | chr19:30161916-30170161 | Brain_Hippocampus_Middle_150 | SE_08055 | chr19:30161921-30164788 | Brain_Inferior_Temporal_Lobe | SE_12389 | chr19:30161691-30165248 | CD3 | SE_15294 | chr19:30161517-30168364 | CD4_Memory_Primary_7pool | SE_16572 | chr19:30161499-30165474 | CD4_Naive_Primary_8pool | SE_18169 | chr19:30155285-30168956 | CD4p_CD25-_CD45ROp_Memory | SE_19560 | chr19:30161728-30168512 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20556 | chr19:30155335-30172521 | CD56 | SE_21321 | chr19:30161657-30165390 | CD8_Memory_7pool | SE_40973 | chr19:30161560-30165126 | Left_Ventricle | SE_41671 | chr19:30162218-30163132 | LNCaP | SE_41671 | chr19:30163219-30167352 | LNCaP | SE_42924 | chr19:30161733-30165058 | Lung | SE_48180 | chr19:30153054-30174554 | Psoas_Muscle | SE_48808 | chr19:30161040-30164995 | Right_Atrium | SE_49565 | chr19:30162474-30163503 | Right_Ventricle | SE_51595 | chr19:30160892-30165284 | Skeletal_Muscle | SE_55264 | chr19:30162098-30165400 | Thymus |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TTCCATGGTA TGTATGTTCC ACATTTTGTT CATCCATTCT CCCATTGACA GACGTTTGAG 60 TTGCTTCCAC CTCTTGGCTA TTGTGAATGA TGCTGATATG AACATGGGAA AGCAGATATT 120 TATTTTAGTC CCTGCTTTCA GTCTGGATAT ATATCCAGAA GTGGCATTGC TGGATCATAT 180 GGTAGTTCTG TTTTTAACCT TTTTTTTTTT TTGAGACGGA GTCTCACTCT GTCGCCCAGG 240 CTGGAGCACA GTGGCGCGAT CTCGGCTCAC TGCAAGCTCC GCCTGCTGGG TTCACGCCAT 300 TCTCCTGCCT CAGCCTCCCG AGTAGCTGGG ACTACAGGCG CTCGCCACCA CACCAGGCTA 360 ATTTTTTGTA TTTTAAGAGA CAGAGTTTCA CCGTGTTGGC CAGGATGGTC TAGATCTCCT 420 GACCTCATGA TCCCCCCTCC TCGGCCTCCC AAAGTGCTGG GATTACAGGC GTGAGTATTT 480 TTAACTTTTT AAGGAACTTC CATGCTGTTT TCCTTAGGGG CTGCACCAGT TCCTATTCTC 540 ATCAGCAGTG CACAGTTTCC AGTTTCTCCA CACCCTCACC AACACTTGTT ATTTATTTTT 600 TGTTTTGTTT TTTTCCCCTC CTTTTTTTTT TTTTGAGATG GAATCTCACT CTGTCACACA 660 GGCTGGAGTG CAATGGCGCC ATCTTGGCTC ACTGCAACCT CTGCTTCCTG GGTTCAAGCG 720 ATTCTCCTGC CTCCGCCTCC CGAGTAGCTG GAATTACAGG TGTGAGGCAC TGTGTCCGGC 780 CTTCCTCCTA CCTATTTTTA TTCATAGATA TAGTTCTTGA ACACTTTCAG AATGTTATGT 840 AATTCCTGCA TAAGTGGTGT CACTTTACAT ACAACATTCT ACAGGCTGTG TTTTTCCACT 900 CCACGTTTGT TGTTTGCCGT CAGACCACAT TGATCTGTAT CTCTCATTGC GTGAGTAGCC 960 CCGGGTTTTT ATCCTTTTCC CTGCTGGTAG GCATTTTGGT TGTCTCTGCT GGGCAGTCAT 1020 TGCTCTTTGT GGAATGCAGT TCTGGTTTTG TCAGATTGTC CCTCAGCCAG GTACTCGGTG 1080 ATCAGTCATG GTGGGACAGG TCAGTTCTGT CACTGGTAAT CCCCTAGGTT TGCAGTATAC 1140 AGCCAAGATC AGCAAGCTAA AAATAGCAGT TCTTACGTAA GGTAGTGTGG GCAGCCCTTC 1200 TCAGGACACT TGTGATCTGC AGGGGCAAGT GGAACGGGAC TCGAGGGCCC AGCATCTTCT 1260 GTTCTGCAAT GCATCCACCC TCACACTGGG GCCCCACTCT GGCTTTCTAC TGGTGGCCAG 1320 GCTCAGAACT GCAGCTCAGT GACCCAGAAA CACTATGGGT GTGATCAGCT CAGCCCCAGG 1380 CGTGCCGTGT GTACCGGAAT GCATGTGTGC ACGTGGTGGT GGTGGGGCCA GCTCTCACCT 1440 CTTCCTCTGT AGAGGTAAGA GCTGAGTCAT GCATGGTGGG CCTTGGGACC TGCTTGGAAC 1500 CGTGCCAAGC TACTTATGAA GCATCTAGTA TGTGCTTGGC ATGGCTCCAA GAATTGTGGA 1560 CACAATGAAC AAGAAGAAGC TCCTGTTCTC ATGGAGCTAA GAACTGAGCA GGGAAGCAGA 1620 AAACACACAA GCAATGAATA GACAAGCAAA CAGCAGGTCC TGTTAAATCC CACAAAGAAA 1680 AACGATTGAA TCCCAGAGAA GTGGCCAGCA GACCTTTTCT ACAAAGGGCC AGGTGGTGAA 1740 TATTTTAGGC TTTGTCACCA TGTAGTCCCT GTCACCAACA CTCAACTCTC CCATTGCAGT 1800 GTGGAAGCCA CCAGAGACAA TAATAAATGA ACGAATGTGG CTGTGTCCCA ATAAATCTTT 1860 AACAAAAGCA GGCTGAGGGC CGGATTTGAC TCTCAGACCT TGGATTACCA ATGCTTGTCC 1920 TGGGTGTGGG AAGAGGCTGC CTGAGCTGGG GTTGTCAGGG AGAACCCTTT CAAAAAGGAA 1980 CTGAGAACCC GTTGCAGGAA GGAGCTGACC CTGGGACAGC CTGTCTCAGG TAGGACACAA 2040 TGGCACCTTG CCACCGATAT GGTGGCGGAG TTATGTGCTG AGAAATGGGC AGGCTAGATT 2100 TGAGAGGTAA AGATGATGAG ATTTACTCAT GGCTTGAATA TTGGAGGTAC AGGAAGGGGG 2160 AGATTCAAGG ATGTGTCCTA GGTCTGGGGT TTGAACTCCT GGATGAATGG TGGTGTCACT 2220 GAAGGAGAGG AAGAGGTGCA GGTCTGCGGA GGTTTGTTGT TGGATGTGTT GAGTTTGAGG 2280 AGCTTATTAG ACAAGCAGGT GAACATCTAT GCTGACAGCC CTCCTAGAGC TTGGAGAGGC 2340 CAAGACTGGA GGCTTGGAAT GGGGAATCTA TGGCATTTAT GGGGTCTTCA AGGTCGTGAG 2400 TCTGGTGGGC TGGTGTGTGT GTGGACCAAG CAGGGGGCGC CCGGCATGAG CTCTGAGTTA 2460 GTGCTTAGTG CTTAGGGCAC CAACAGAGGG GCCTGTGTGG CCTCACACTC CACTCGGGAC 2520 GGCAGCATAG TGCGAGCTCC AGGGCCCCTG CCTCCTAGCA TCGCCTCAGT TCCCCTCCTG 2580 TAAAGTGGGG ATTCTGCCTT CTGGGGTTGG GTGGGAACTA AATGAGATAG TCACGCTTGG 2640 CTGACAGGAA GCACTCGGCG CCTGTGCTTG TGATGGTGGT GGTGACTGCT GCACTTCCTG 2700 GGTGGTTGCG TGGGTTGCAG GGCCTGTGAC AGCTTGGTTT GGTGGATGGC AGAGTCAGGG 2760 TTGGGTTGGG GGTAGAGACA CCCAGGTCTC CTGGCACAGA CCGTTCTGAT GTCCCGTTGA 2820 GGCCTGTTCC GCCCTGTTTT TCAAGGCTCC CCAGCGGGGC TGAACCTCTG CCCTCTGCTG 2880 CCCACAGTAG TAGCCGGCTC AGTAGCACTT TTTTTTTTTA AGAGATAGAA TCCACTCAGT 2940 CACCTAGCTA GAGTGTAGTG GCATGATCAT AGCTCACTGT AGCCTCAAAC TCCTGGGCTC 3000 GAGCCTCCTC TTGCCTCAGC CTTCCAAAAC GCTGGAACCA CAGGCATGAA CCGCTGCACC 3060 TGGCCTAAGT AGCACACTTT ATCACTGCCT TCCCATCCCT GTCTGGCCTC CACATCCCCT 3120 TTACTGGGAA ATCCCCCTTC CCTCCCCGTA GTTCCCTGTA CTCCCGTCTA AGGGTCAGCT 3180 TCCGAGGTGA TGCTTCTCAG TGCTGGGCAG GCCTGCGGGT TACTGTGCGT AGTCAGTGGG 3240 CTGCCTGGCA TGGTGGGTTA GTCAGTTGGG GGTGGGCAGC GTGGTTCTGA CACCCCCATG 3300 CCTGAGCCTG GACATACTCC TTGTCTGTCT CCTCCTGCAG 3340
|